Signal active
Investment Firm
Overview
National Institutes of Health is a biomedical research facility in the United States. It is affiliated with the United States Department of Health and Human Services. It is the primary agency of the United States government responsible for biomedical and health-related research. It conducts its own scientific research through its Intramural Research Program (IRP) and provides major biomedical research funding to non-NIH research facilities through its Extramural Research Program.
National Institutes of Health has 1,200 principal investigators and more than 4,000 postdoctoral fellows in basic, translational, and clinical research. It comprises 27 separate institutes and centers that conduct research in different disciplines of biomedical science.
With scientific accomplishments such as the discovery of fluoride to prevent tooth decay, the use of lithium to manage bipolar disorder, the creation of vaccines against hepatitis, Haemophilus influenzae (HIB), and human papillomavirus, National Institutes of Health has many agencies under its control.
National Institutes of Health was established in 1887. It is based in Bethesda, Maryland.
Highlights
1887
Biotechnology
10001+
889
640
89
Seed, Early Stage Venture, Late Stage Venture
Entrepreneurship Program
Location
United States, North America
Contact Information
Social
Profile Resume
National Institutes of Health, established in 1887 and headquartered in United States, North America., specializes in Seed, Early Stage Venture, Late Stage Venture investments across Manufacturing, Transaction Processing, Product Design, Biotechnology, Medical, Health Diagnostics, Pharmaceutical, Biopharma, Big Data, Genetics. The organization boasts a portfolio of 882 investments, with an average round size of $9.3M and 89 successful exits. Their recent investments include PlastiPure, Akonni Biosystems, Selecta Biosciences, Maven Biotechnologies, Natera. The highest investment round they participated in was $71.0B. Among their most notable exits are PlastiPure and Akonni Biosystems. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
889
199
640
89
Investments
889
Annouced Date | Organization Name | Industry | Money Raised |
---|---|---|---|
Jul 22, 2024 | MaMome | Biotechnology | 300.0K |
Jul 31, 2024 | Cortechs.ai | Software | null |
Aug 05, 2024 | - | - | 4.5M |
Aug 05, 2024 | University of Arkansas for Medical Sciences | Health Care | null |
Exits
89
Funding Timeline
889
0
0
Funding Rounds
889
National Institutes of Health has raised 889 rounds. Their latest funding was raised on Aug 05, 2024 from a Grant - University of Arkansas for Medical Sciences round.
Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
---|---|---|---|---|
Jul 22, 2024 | Grant - MaMome | - | 300.0K | - |
Jul 31, 2024 | Grant - Cortechs.ai | - | 0 | - |
Aug 05, 2024 | Grant - Immunovia | - | 4.5M | - |
Aug 05, 2024 | Grant - University of Arkansas for Medical Sciences | - | 0 | - |
Investors
1
Investor Name | Lead Investor | Funding Round | Money Raised |
---|---|---|---|
- | No | Grant - National Institutes of Health | 5.0M |
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
Annouced Date | Fund Name | Money Raised |
---|---|---|
May 10, 2013 | OTPPLESS | 1.0M |
May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.